• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-1/miR-133的下调有助于肥厚心脏中起搏通道基因HCN2和HCN4的重新表达。

Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart.

作者信息

Luo Xiaobin, Lin Huixian, Pan Zhengwei, Xiao Jiening, Zhang Yong, Lu Yanjie, Yang Baofeng, Wang Zhiguo

机构信息

Research Center, Montreal Heart Institute, Montreal, PQ, Canada.

出版信息

J Biol Chem. 2008 Jul 18;283(29):20045-52. doi: 10.1074/jbc.M801035200. Epub 2008 May 5.

DOI:10.1074/jbc.M801035200
PMID:18458081
Abstract

Cardiac hypertrophy is characterized by electrical remolding with increased risk of arrhythmogenesis. Enhanced abnormal automaticity of ventricular cells contributes critically to hypertrophic arrhythmias. The pacemaker current I(f), carried by the hyperpolarization-activated channels encoded mainly by the HCN2 and HCN4 genes in the heart, plays an important role in determining cardiac automaticity. Their expressions reportedly increase in hypertrophic and failing hearts, contributing to arrhythmogenesis under these conditions. We performed a study on post-transcriptional regulation of expression of HCN2 and HCN4 genes by microRNAs. We experimentally established HCN2 as a target for repression by the muscle-specific microRNAs miR-1 and miR-133 and established HCN4 as a target for miR-1 only. We unraveled robust increases in HCN2 and HCN4 protein levels in a rat model of left ventricular hypertrophy and in angiotensin II-induced neonatal ventricular hypertrophy. The up-regulation of HCN2/HCN4 was accompanied by pronounced reduction of miR-1/miR-133 levels. Forced expression of miR-1/miR-133 by transfection prevented overexpression of HCN2/HCN4 in hypertrophic cardiomyocytes. The serum-responsive factor protein level was found significantly decreased in hypertrophic hearts, and silencing of this protein by RNA interference resulted in increased levels of miR-1/miR-133 and concomitant increases in HCN2 and HCN4 protein levels. We conclude that down-regulation of miR-1 and miR-133 expression contributes to re-expression of HCN2/HCN4 and thereby the electrical remodeling process in hypertrophic hearts. Our study also sheds new light on the cellular function and pathological role of miR-1/miR-133 in the heart.

摘要

心肌肥厚的特征是电重构,心律失常发生风险增加。心室细胞异常自律性增强是肥厚性心律失常的关键因素。心脏中主要由HCN2和HCN4基因编码的超极化激活通道所携带的起搏电流I(f),在决定心脏自律性方面起重要作用。据报道,它们在肥厚和衰竭心脏中的表达增加,在这些情况下促成心律失常的发生。我们进行了一项关于微小RNA对HCN2和HCN4基因表达的转录后调控的研究。我们通过实验确定HCN2是肌肉特异性微小RNA miR-1和miR-133的抑制靶点,并且确定HCN4仅是miR-1的靶点。我们发现在左心室肥厚大鼠模型和血管紧张素II诱导的新生大鼠心室肥厚中,HCN2和HCN4蛋白水平显著升高。HCN2/HCN4的上调伴随着miR-1/miR-133水平的明显降低。通过转染强制表达miR-1/miR-133可防止肥厚性心肌细胞中HCN2/HCN4的过表达。在肥厚心脏中发现血清反应因子蛋白水平显著降低,通过RNA干扰使该蛋白沉默导致miR-1/miR-133水平升高以及HCN2和HCN4蛋白水平随之升高。我们得出结论,miR-1和miR-133表达下调促成HCN2/HCN4的重新表达,从而导致肥厚心脏中的电重构过程。我们的研究还为miR-1/miR-133在心脏中的细胞功能和病理作用提供了新的线索。

相似文献

1
Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart.miR-1/miR-133的下调有助于肥厚心脏中起搏通道基因HCN2和HCN4的重新表达。
J Biol Chem. 2008 Jul 18;283(29):20045-52. doi: 10.1074/jbc.M801035200. Epub 2008 May 5.
2
Transcriptional control of pacemaker channel genes HCN2 and HCN4 by Sp1 and implications in re-expression of these genes in hypertrophied myocytes.Sp1对起搏通道基因HCN2和HCN4的转录调控及其在肥大心肌细胞中这些基因重新表达中的意义。
Cell Physiol Biochem. 2009;23(4-6):317-26. doi: 10.1159/000218178. Epub 2009 May 6.
3
Associated changes in HCN2 and HCN4 transcripts and I(f) pacemaker current in myocytes.心肌细胞中HCN2和HCN4转录本及I(f)起搏电流的相关变化。
Biochim Biophys Acta. 2009 May;1788(5):1138-47. doi: 10.1016/j.bbamem.2009.02.011. Epub 2009 Feb 21.
4
Novel approaches for gene-specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4.通过操纵微小RNA的作用实现基因特异性干扰的新方法:对起搏通道基因HCN2和HCN4的研究
J Cell Physiol. 2007 Aug;212(2):285-92. doi: 10.1002/jcp.21062.
5
Proteolytic processing of HCN2 and co-assembly with HCN4 in the generation of cardiac pacemaker channels.心脏起搏器通道生成过程中HCN2的蛋白水解加工及与HCN4的共组装。
J Biol Chem. 2009 Sep 18;284(38):25553-9. doi: 10.1074/jbc.M109.007583. Epub 2009 Jul 1.
6
Dynamic changes in HCN2, HCN4, KCNE1, and KCNE2 expression in ventricular cells from acute myocardial infarction rat hearts.急性心肌梗死大鼠心室细胞中 HCN2、HCN4、KCNE1 和 KCNE2 表达的动态变化。
Biochem Biophys Res Commun. 2010 May 7;395(3):330-5. doi: 10.1016/j.bbrc.2010.04.003. Epub 2010 Apr 8.
7
Dominant-negative suppression of HCN channels markedly reduces the native pacemaker current I(f) and undermines spontaneous beating of neonatal cardiomyocytes.HCN通道的显性负性抑制显著降低了天然起搏电流I(f),并破坏了新生心肌细胞的自发搏动。
Circulation. 2003 Jan 28;107(3):485-9. doi: 10.1161/01.cir.0000045672.32920.cb.
8
Ventricular HCN channels decrease the repolarization reserve in the hypertrophic heart.心室 HCN 通道减少肥厚心脏的复极化储备。
Cardiovasc Res. 2012 Aug 1;95(3):317-26. doi: 10.1093/cvr/cvs184. Epub 2012 May 31.
9
Molecular basis of funny current (If) in normal and failing human heart.正常和衰竭的人类心脏中起搏电流(If)的分子基础。
J Mol Cell Cardiol. 2008 Aug;45(2):289-99. doi: 10.1016/j.yjmcc.2008.04.013. Epub 2008 May 11.
10
Sinus node dysfunction and hyperpolarization-activated (HCN) channel subunit remodeling in a canine heart failure model.犬心力衰竭模型中的窦房结功能障碍与超极化激活(HCN)通道亚单位重塑
Cardiovasc Res. 2005 Jun 1;66(3):472-81. doi: 10.1016/j.cardiores.2005.02.011. Epub 2005 Mar 21.

引用本文的文献

1
The Potential Contribution of MyomiRs miR-133a-3p, -133b, and -206 Dysregulation in Cardiovascular Disease Risk.肌微RNA-133a-3p、-133b和-206失调在心血管疾病风险中的潜在作用
Int J Mol Sci. 2024 Nov 27;25(23):12772. doi: 10.3390/ijms252312772.
2
Shensong yangxin, a multi-functional traditional Chinese medicine for arrhythmia: A review of components, pharmacological mechanisms, and clinical applications.参松养心——一种用于治疗心律失常的多功能中药:成分、药理机制及临床应用综述
Heliyon. 2024 Aug 2;10(16):e35560. doi: 10.1016/j.heliyon.2024.e35560. eCollection 2024 Aug 30.
3
MicroRNAs: Midfielders of Cardiac Health, Disease and Treatment.
MicroRNAs:心脏健康、疾病和治疗的中场球员。
Int J Mol Sci. 2023 Nov 11;24(22):16207. doi: 10.3390/ijms242216207.
4
The Interplay Between Gut Microbiota and miRNAs in Cardiovascular Diseases.肠道微生物群与微小RNA在心血管疾病中的相互作用
Front Cardiovasc Med. 2022 Mar 16;9:856901. doi: 10.3389/fcvm.2022.856901. eCollection 2022.
5
Upregulation of Circulating Cardiomyocyte-Enriched miR-1 and miR-133 Associate with the Risk of Coronary Artery Disease in Type 2 Diabetes Patients and Serve as Potential Biomarkers.循环心肌细胞高表达的 miR-1 和 miR-133 与 2 型糖尿病患者的冠心病风险相关,并可作为潜在的生物标志物。
J Cardiovasc Transl Res. 2019 Aug;12(4):347-357. doi: 10.1007/s12265-018-9857-2. Epub 2019 Jan 4.
6
Noncoding RNAs in Cardiac Hypertrophy.非编码 RNA 在心脏肥大中的作用。
J Cardiovasc Transl Res. 2018 Dec;11(6):439-449. doi: 10.1007/s12265-018-9797-x. Epub 2018 Aug 31.
7
HDncRNA: a comprehensive database of non-coding RNAs associated with heart diseases.HDncRNA:一个与心脏疾病相关的非编码 RNA 综合数据库。
Database (Oxford). 2018 Jan 1;2018. doi: 10.1093/database/bay067.
8
Effect of Wenxin Granules on Gap Junction and MiR-1 in Rats with Myocardial Infarction.稳心颗粒对心肌梗死大鼠缝隙连接及 miR-1 的影响。
Biomed Res Int. 2017;2017:3495021. doi: 10.1155/2017/3495021. Epub 2017 Sep 28.
9
MicroRNAs and cardiovascular medicine.微小RNA与心血管医学
SAGE Open Med. 2014 Mar 12;2:2050312114524952. doi: 10.1177/2050312114524952. eCollection 2014.
10
MicroRNA-302b Enhances the Sensitivity of Hepatocellular Carcinoma Cell Lines to 5-FU via Targeting Mcl-1 and DPYD.微小RNA-302b通过靶向Mcl-1和DPYD增强肝癌细胞系对5-氟尿嘧啶的敏感性。
Int J Mol Sci. 2015 Oct 6;16(10):23668-82. doi: 10.3390/ijms161023668.